By Claire Guzior
on May 26, 2023
The FDA approved the drug semaglutide for those suffering from obesity, diabetes, and other weight-related illnesses. Since its approval, semaglutide has faced worldwide popularity — resulting in supply shortages.
By Thea Le Fevre
on May 17, 2023
The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers.
By LegitScript Folks
on March 27, 2023
Before 2020, when the pandemic limited access to in-person healthcare, telehealth was growing only incrementally and some well-meaning laws made it difficult to access certain medications. Now, newly proposed federal rules take into account how society has changed in a post-COVID world, and how it’s impacted the prescribing of controlled substances online. Read more to understand what new rules the DEA is proposing, and their potential to permanently change the telemedicine landscape.
By David Khalaf
on March 20, 2023
We get a lot of questions about LegitScript's best-in-class Merchant Monitoring solution: How does it work? What are its features? What makes it different from other merchant monitoring service providers? We're going to answer all of these questions for you and more so you can understand if LegitScript's solution is right for you. In this…
on March 15, 2023
LegitScript’s Domain Name Enforcement program reports illicit websites' domain names to their associated registrars. Read more to understand what a domain registrar is, and how we report domain names.
on March 09, 2023
Get Your Copy of the Tip Sheet Reviewing merchant websites can be both difficult and time consuming. LegitScript’s tip sheet gives you tools to more easily identify common red flags for merchants engaged in high-risk businesses. Designed in a checklist-style format, we offer advice for common problematic categories, including: Supplement and pharmaceutical websites Scammy-looking websites…
on March 06, 2023
Bad actors may change their methodologies as technology evolves, but the same offerings emerge year after year. In this recap of LegitScript’s recent webinar, we identify and track seasonal high-risk trends in payment processing and on e-commerce platforms to help you anticipate them. Read more to understand what these trends are and how to grow your business more confidently.
on February 28, 2023
LegitScript Announces New Organizational Structure to Accelerate and Expand Its Certification Solutions A dedicated business unit reinforces LegitScript’s commitment to growing its certification programs and improving the customer experience. LegitScript, the leader in merchant and product certification and monitoring in the e-commerce and payment sectors, announces a new organizational structure to improve the company’s existing…
on February 15, 2023
LegitScript is pleased to announce a collaboration with Locke Bio to help new and emerging digital healthcare providers grow their business while navigating telehealth’s complex compliance requirements. Locke Bio is a digital health platform company dedicated to helping any enterprise launch a fully integrated, branded telehealth service.
on February 06, 2023
The FDA recently updated its rules to remove the in-person dispensing requirement for a well-known abortion drug. Read this blog post to understand how rule changes related to the COVID-19 pandemic influenced the FDAs decision, what modifications were made, and how healthcare providers that are LegitScript-certified can stay abreast of trends and maintain compliance.